TMZ toxicity is primarily linked to O6-MeG production and glioma response to TMZ therapy is inversely associated with expression of MGMT, a key protein responsible for the repair of O6-MeG base lesions.6–9 We asked whether MGMT attenuates XAF1 response to TMZ. The gene discussed is MGMT; the disease is glioma.